Business
Iofina becomes founding member of the WIA
Iofina becomes founding member of the WIA.
About this update from Iofina Plc
[{"type":"text","content":"\n \nRNS Number : 3574C Iofina PLC 15 October 2015 \n\n \n15 October 2015\n \nIofina plc\n(\"Iofina\" or the \"Company\")\n(LSE AIM: IOF)\n \nIofina becomes founding member of the World Iodine Association\n \nIofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to announce it has become a founding member of the World Iodine Association (\"WIA\"), launched on 14 October 2015 to promote iodine uses and to help eradicate global iodine deficiency.\n \nThe mission of the WIA is to support and represent iodine producers, processors, formulators, distributors and end-users in relevant industry and official government bodies around the world, with respect to guidelines and regulations on iodine and its derivatives. Alongside Iofina, other founding members of the WIA includes Ajay Europe, Calibre Chemicals, GE Healthcare, Hypred SAS and SQM Europe.\n \nThe WIA develops, supports and promotes the use of iodine and its derivatives in existing and novel uses and applications in the domains of human and animal health and industry. The WIA provides information about the purposes, uses and applications of iodine and its derivatives to interested parties and aims to help eradicate global iodine deficiency.\n \nMore information on the WIA can be found at www.worldiodineassociation.com.\n \nCommenting on today's landmark news, CEO & President Tom Becker said:\n \n\"Becoming a founding member of the WIA, alongside a series of prestigious names within our industry, is an important step for a company like Iofina which remains on track to become the second largest producer of Iodine in North America. The formation of the WIA is a highly positive step towards the promotion of iodine and the impact that will have in numerous applications including both animal and human health and nutrition.\"\n \n \n \nFor further information, please contact: &...